BFC Planning’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
Other funds holding LPCN
BFC Planning's LPCN Position: Q3 2026 in Review
BFC Planning held its Lipocine (LPCN) position steady in Q3 2026 at 1,324 shares worth $2.91K. The position accounts for ﹤0.01% of the portfolio, ranked #2894.
BFC Planning first reported a position in LPCN in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.39K in Q2 2026. 24 funds tracked by Wall St. Rank hold LPCN as of Q3 2026.
- BFC Planning held 1,324 shares of Lipocine worth $2.91K as of Q3 2026.
- BFC Planning left its Lipocine share count unchanged in Q3 2026.
- Lipocine made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2894 holding.
- BFC Planning first reported a position in Lipocine in Q2 2026 and has held it in 2 quarters since.
- BFC Planning's Lipocine position peaked at $3.39K in Q2 2026.
- 24 funds tracked by Wall St. Rank held Lipocine as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.